Huge new medical dataset
September 13, 2016
Australian data insights firm Protogen Technologies says a new dataset it has developed in partnership with Medical Director has the potential for driving change in both health policy and clinical pathways across the country.
Protogen says it's "one of the best primary healthcare datasets in the world," comprising key general practice data on more than four million anonymous patient records between 2005 and 2016.
"It is countrywide, covers significant areas of interest for policy makers and represents years of potential research in clinical, logistical and financial outcomes," said ceo Mark Grosser.
He said the company had extracted over 200 gigabytes of raw data including clinical information and details of prescriptions, infrastructure and Medicare claims across Australia.
"The size of this dataset is enormous, over one hundred times the size of the raw Panama Papers," said Protogen chief technology officer, Omer Ingber.
Medical Director, which was recently acquired by private equity firm Affinity Equity Partners, is working with Protogen on the next steps to enhance both the data being gathered as well as further analysis and research of the data.
The Protogen platform allows population health research to be performed rapidly, providing analysis by national, state, postcode, city and practice.
It has applications on the impact of health policy in primary care, the most common treatments for particular diseases, correlation between socioeconomics and disease and real evidence based medicine, Protogen said.
Further steps could include working with other data sources as well as "genomics driven precision based medicine," the firm added.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Sep 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Sep 16
